For the readers interested in the stock health of Clovis Oncology Inc. (CLVS). It is currently valued at $6.25. When the transactions were called off in the previous session, Stock hit the highs of $6.42, after setting-off with the price of $6.14. Company’s stock value dipped to $6.07 during the trading on the day. When the trading was stopped its value was $6.14.
Recently in News on April 10, 2021, Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021. Findings from the Phase 1b RAMP study evaluating the combination of Rubraca and Xtandi® (enzalutamide) in men with unselected mCRPC lay the groundwork for the Phase 3 CASPAR study which is expected to begin enrolling patients shortly. You can read further details here
Clovis Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.10 on 02/08/21, with the lowest value was $4.73 for the same time period, recorded on 01/06/21.
Clovis Oncology Inc. (CLVS) full year performance was -12.10%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clovis Oncology Inc. shares are logging -43.69% during the 52-week period from high price, and 53.19% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.08 and $11.10.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3697657 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Clovis Oncology Inc. (CLVS) recorded performance in the market was 30.21%, having the revenues showcasing 4.69% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 690.00M, as it employees total of 429 workers.
Market experts do have their say about Clovis Oncology Inc. (CLVS)
During the last month, 0 analysts gave the Clovis Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.13, with a change in the price was noted +1.86. In a similar fashion, Clovis Oncology Inc. posted a movement of +42.37% for the period of last 100 days, recording 10,610,709 in trading volumes.
Technical breakdown of Clovis Oncology Inc. (CLVS)
Raw Stochastic average of Clovis Oncology Inc. in the period of last 50 days is set at 19.97%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.23%. In the last 20 days, the company’s Stochastic %K was 24.41% and its Stochastic %D was recorded 25.62%.
Bearing in mind the latest performance of Clovis Oncology Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 30.21%. Additionally, trading for the stock in the period of the last six months notably improved by 12.82%, alongside a downfall of -12.10% for the period of the last 12 months. The shares increased approximately by -5.02% in the 7-day charts and went down by 6.29% in the period of the last 30 days. Common stock shares were driven by 4.69% during last recorded quarter.